Literature DB >> 16877186

Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study.

Olav Magnus S Fredheim1, Petter C Borchgrevink, Lars Hegrenaes, Stein Kaasa, Ola Dale, Pål Klepstad.   

Abstract

Case reports and retrospective studies suggest that methadone causes an increase in QTc (QT time corrected for heart rate) time and risk of torsades de pointes arrhythmia. No prospective studies in pain patients have been conducted, and data on whether a methadone-induced increase in QTc time persists during long-term treatment have not been reported. Eight chronic nonmalignant pain patients experiencing insufficient pain control or intolerable side effects during treatment with oral morphine switched to oral methadone and were included in this study. Electrocardiograms were obtained at baseline and at follow-up 2 weeks, and 3 and 9 months after the opioid switch. Start of methadone caused a minor but statistically significant increase in QTc time, while fluctuations in QTc during treatment with stable doses of methadone were neither clinically nor statistically significant. We observed no episodes of arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877186     DOI: 10.1016/j.jpainsymman.2006.02.010

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  15 in total

1.  Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature.

Authors:  David W Abramson; Davin K Quinn; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  Case files of the Drexel University Medical Toxicology Fellowship: methadone-induced QTc prolongation.

Authors:  Stella C Wong; James R Roberts
Journal:  J Med Toxicol       Date:  2007-12

3.  Changes of QTc interval after opioid switching to oral methadone.

Authors:  Sebastiano Mercadante; Giovanna Prestia; Claudio Adile; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2013-08-15       Impact factor: 3.603

Review 4.  Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?

Authors:  Sobia Mujtaba; Jorge Romero; Cynthia C Taub
Journal:  J Cardiovasc Dis Res       Date:  2013-11-16

5.  Methadone initiation and rotation in the outpatient setting for patients with cancer pain.

Authors:  Henrique A Parsons; Maxine de la Cruz; Badi El Osta; Zhijun Li; Bianca Calderon; J Lynn Palmer; Eduardo Bruera
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

Review 6.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

7.  Methadone prolongs cardiac conduction in young patients with cancer-related pain.

Authors:  Doralina L Anghelescu; Rakesh M Patel; Daniel P Mahoney; Luis Trujillo; Lane G Faughnan; Brenda D Steen; Justin N Baker; Deqing Pei
Journal:  J Opioid Manag       Date:  2016 May-Jun

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

9.  The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.

Authors:  Suresh Reddy; David Hui; Badi El Osta; Maxine de la Cruz; Paul Walker; J Lynn Palmer; Eduardo Bruera
Journal:  J Palliat Med       Date:  2010-01       Impact factor: 2.947

10.  The successful use of parenteral methadone in a patient with a prolonged QTc interval.

Authors:  Ryuichi Sekine; Eugenie A M T Obbens; Nessa Coyle; Charles E Inturrisi
Journal:  J Pain Symptom Manage       Date:  2007-07-05       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.